We are investigating cell-based gene transfer approaches to treat the central nervous system (CNS) component of lysosomal storage disorders. Animal models of mucopolysaccharidosis (MPS) VII (ly disease), beta- glucuronidase (GUSB) deficiency, are used as test systems. Treatment is based on lysosomal enzymes being secreted from genetically corrected cells, diffusing through tissue, and being taken up by mutant cells to restore the missing enzymatic activity. We have demonstrated that gene therapy can work, in principle, in the brains of MPS VII mice. However, there are still substantial barriers to achieving permanent and complete correction, particularly of the global lesions that occur in the brain. We have made significant progress towards solving some of the major problems by: 1) developing a retrovirus vector, a noel cell isolation method, which each appear to overcome the problem of vector extinction in vivo; 2) demonstrating that vector-expressed normal enzyme can diffuse through neural tissue and correct affected neurons at a distance; and 3) showing that a neural stem cell line can deliver enzyme widely in the host brain and differentiate into normal brain elements, and developing new neural stem cell lines to test gene delivery strategies. For the next grant period, we propose to use the MPS VII mouse brain to: 1) measure the sphere of enzyme diffusion that can be achieved from grafts that are continuously secreting high levels, and determine the extent of phenotypic correction, 2) determine if delivery to the diseased brain cells can be improved by engineering the enzyme protein; and 3) determine if syngeneic neural stem cells, transduced with our new vector, can distribute therapeutic enzyme in a global fashion. We will also test the methods in MPS VII dogs to measure the distribution of enzyme in a brain which is 200 times larger in volume than a mouse brain. These studies will define the limitations that are likely to be encountered in trying to treat an affected child's brain, which is only about 1o times larger than the dog brain.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK042707-12
Application #
6177323
Study Section
Medical Biochemistry Study Section (MEDB)
Program Officer
Mckeon, Catherine T
Project Start
1995-04-01
Project End
2003-06-30
Budget Start
2000-07-01
Budget End
2001-06-30
Support Year
12
Fiscal Year
2000
Total Cost
$341,531
Indirect Cost
Name
Children's Hospital of Philadelphia
Department
Type
DUNS #
073757627
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Walton, Raquel M; Wolfe, John H (2007) Abnormalities in neural progenitor cells in a dog model of lysosomal storage disease. J Neuropathol Exp Neurol 66:760-9
Watson, Deborah J; Walton, Raquel M; Magnitsky, Sergey G et al. (2006) Structure-specific patterns of neural stem cell engraftment after transplantation in the adult mouse brain. Hum Gene Ther 17:693-704
Watson, Deborah J; Passini, Marco A; Wolfe, John H (2005) Transduction of the choroid plexus and ependyma in neonatal mouse brain by vesicular stomatitis virus glycoprotein-pseudotyped lentivirus and adeno-associated virus type 5 vectors. Hum Gene Ther 16:49-56
Jiang, Kanli; Watson, Deborah J; Wolfe, John H (2005) A genetic fusion construct between the tetanus toxin C fragment and the lysosomal acid hydrolase beta-glucuronidase expresses a bifunctional protein with enhanced secretion and neuronal uptake. J Neurochem 93:1334-44
Magnitsky, S; Watson, D J; Walton, R M et al. (2005) In vivo and ex vivo MRI detection of localized and disseminated neural stem cell grafts in the mouse brain. Neuroimage 26:744-54
Watson, Deborah J; Karolewski, Brian A; Wolfe, John H (2004) Stable gene delivery to CNS cells using lentiviral vectors. Methods Mol Biol 246:413-28
Longhi, Luca; Watson, Deborah J; Saatman, Kathryn E et al. (2004) Ex vivo gene therapy using targeted engraftment of NGF-expressing human NT2N neurons attenuates cognitive deficits following traumatic brain injury in mice. J Neurotrauma 21:1723-36
Watson, Deborah J; Longhi, Luca; Lee, Edward B et al. (2003) Genetically modified NT2N human neuronal cells mediate long-term gene expression as CNS grafts in vivo and improve functional cognitive outcome following experimental traumatic brain injury. J Neuropathol Exp Neurol 62:368-80
Karolewski, Brian A; Watson, Deborah J; Parente, Michael K et al. (2003) Comparison of transfection conditions for a lentivirus vector produced in large volumes. Hum Gene Ther 14:1287-96
Watson, Deborah J; Wolfe, John H (2003) Lentiviral vectors for gene transfer to the central nervous system. Applications in lysosomal storage disease animal models. Methods Mol Med 76:383-403

Showing the most recent 10 out of 37 publications